Health Insurance Zug
Health Insurance Zug
ProLiant (R) (Denosumab) approved for marketing in the European Union Thousand Oaks, Calif., May 28, 2010 (ots / PRNewswire) – Amgen announced today that the European Commission (EC) has granted permission for ProLiant (R) (denosumab) for the treatment of osteoporosis postmenopausal women to …
